DrugPatentWatch Database Preview
Drugs in Development Information for Tegafur
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Tegafur?
Tegafur is an investigational drug.
There have been 122 clinical trials for Tegafur.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2014.
The most common disease conditions in clinical trials are Stomach Neoplasms, Colorectal Neoplasms, and Carcinoma. The leading clinical trial sponsors are Fudan University, Taiho Pharmaceutical Co., Ltd., and National Taiwan University Hospital.
There are two US patents protecting this investigational drug and twenty-nine international patents.
Summary for Tegafur
| US Patents | 2,618 |
| International Patents | 29,012 |
| US Patent Applications | 5,863 |
| WIPO Patent Applications | 907 |
| Japanese Patent Applications | 11 |
| Clinical Trial Progress | Phase 3 (2014-09-01) |
| Vendors | 63 |
Recent Clinical Trials for Tegafur
| Title | Sponsor | Phase |
|---|---|---|
| Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma | RenJi Hospital | Phase 2 |
| Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer | Fudan University | Phase 2 |
| A Study of Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer | CSPC Ouyi Pharmaceutical Co., Ltd. | Phase 3 |
Clinical Trial Summary for Tegafur
Top disease conditions for Tegafur
Top clinical trial sponsors for Tegafur
US Patents for Tegafur
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tegafur | Start Trial | Heterocyclic compounds useful in the treatment of disease | Epigen Biosciences, Inc. (San Diego, CA) | Start Trial |
| Tegafur | Start Trial | Heterocyclic compound | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| Tegafur | Start Trial | Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same | Protalix Ltd. (Carmiel, IL) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tegafur
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tegafur | Australia | 2014232383 | 2033-03-15 | Start Trial |
| Tegafur | Australia | 2019202731 | 2033-03-15 | Start Trial |
| Tegafur | Brazil | 112015023267 | 2033-03-15 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
